| Income Statement |
| Total Revenue | 50.56M |
|
| Revenues (USD) | 58.12M |
| Cost of Revenue | 21.16M |
| Gross Profit | 29.40M |
| Operating Expenses | 43.27M |
| Research and Development Expense | 8.88M |
| Selling, General and Administrative Expense | 23.03M |
| Operating Income | -13.87M |
| Interest Expense | 4.41M |
| Income Tax Expense | -92.00K |
| Net Income | -17.73M |
| Net Income Common Stock | -17.73M |
| Net Income Common Stock (USD) | -20.38M |
| Consolidated Income | -17.73M |
| Net Income to Non-Controlling Interests | 3.00K |
| Earning Before Interest & Taxes (EBIT) | -13.41M |
| Earning Before Interest & Taxes (USD) | -15.42M |
| Weighted Average Shares | 247.71M |
| Balance Sheet |
| Cash and Equivalents | 61.46M |
| Cash and Equivalents (USD) | 70.65M |
| Investments | 1.10M |
| Investments Current | 1.10M |
| Trade and Non-Trade Receivables | 10.57M |
| Current Assets | 93.92M |
| Property, Plant & Equipment Net | 16.67M |
| Total Assets | 111.98M |
| Debt Current | 2.99M |
| Total Debt | 9.66M |
| Current Liabilities | 91.89M |
| Debt Non-Current | 6.67M |
| Total Liabilities | 99.44M |
| Accumulated Retained Earnings (Deficit) | -2.25B |
| Shareholders Equity | 13.07M |
| Shareholders Equity (USD) | 15.03M |
| Assets Non-Current | 18.06M |
| Total Debt (USD) | 11.11M |
| Deferred Revenue | 3.45M |
| Inventory | 8.43M |
| Liabilities Non-Current | 7.54M |
| Trade and Non-Trade Payables | 56.42M |
| Tax Assets | 6.53M |
| Tax Liabilities | 21.46M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.12M |
| Net Cash Flow from Financing | -1.61M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -14.26M |
| Capital Expenditure | -601.00K |
| Issuance (Repayment) of Debt Securities | -1.61M |
| Net Cash Flow from Investing | -186.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | 149.00K |
| Net Cash Flow from Operations | -12.46M |
| Effect of Exchange Rate Changes on Cash | -950.00K |
| Share Based Compensation | 798.00K |